Salivary Cortisol Increases After Bariatric Surgery in Women

Abstract

Cortisol increases have been associated with psychological and physiological stress; however, cortisol dynamics after weight loss (bariatric) surgery have not been defined. Obese participants not using exogenous glucocorticoids were eligible to participate. Female participants (n=24) provided salivary cortisol samples at bedtime, upon awakening the following morning, and 30 min after awakening before, and at 6 or 12 months after bariatric surgery. The Medical Outcomes Study Short Form-12 version 2 questionnaire regarding health-related quality of life was also completed. Preoperatively, mean body mass index was 45.1±8.1 kg/m². Mean late night (1.8±1.1 nmol/l), awakening (10.7±7.4 nmol/l), and after-awakening (11.5±7.9 nmol/l) salivary cortisol values were within normal ranges. The cortisol awakening response (mean 21.1±79.7%, median 13.7%) was at the low end of normal. Preoperatively, participants had lower mental and physical health-related quality of life scores than US adult norms (p<0.001). Salivary cortisol was not correlated with measures of health-related quality of life. Mean BMI decreased over time (p<0.001) and participants experienced improved physical and mental health-related quality of life (p≤0.011). Postoperative late night salivary cortisol was not different from preoperative values. Awakening and after-awakening cortisol levels were higher than preoperative values (15.3±7.7 nmol/l, p=0.013; 17.5±10.2 nmol/l, p=0.005; respectively), but the cortisol awakening response was not changed (mean 26.7±66.2%; median 7.8%). Morning salivary cortisol increased at long-term follow-up after bariatric surgery. Although self-evaluated mental and physical health improved after surgery, the cortisol awakening response is at the low end of normal, which may indicate continued physiological stress.

• References

• 1 Maggard M, Li Z, Yermilov I, Maglione M, Suttorp M, Carter J, Tringale C, Hilton L, Chen S, Shekelle P. Bariatric Surgery in Women of Reproductive Age: Special Concerns for Pregnancy. Evidence Report/Technology Assessment No. 169. (Prepared by the Southern California Evidence-based Practice Center under Contract No. 290-02-003). November 2008. Rockville, MD: Agency for Healthcare Research and Quality;
• 2 Adam EK, Kumari M. Psychoneuroendocrinology 2009; 34: 1423-1436
• 3 Nguyen NT, Goldman CD, Ho HS, Gosselin RC, Singh A, Wolfe BM. J Am Coll Surg 2002; 194: 557-566
• 4 Vining RF, McGinley RA, Maksvytis JJ, Ho KY. Ann Clin Biochem 1983; 20: 329-335
• 5 Rubin GJ, Hotopf M, Papadopoulos A, Cleare A. Psychosom Med 2005; 67: 441-447
• 6 Tomiyama AJ, Mann T, Vinas D, Hunger JM, Dejager J, Taylor SE. Psychosom Med 2010; 72: 357-364
• 7 Holty JE, Parimi N, Ballesteros M, Blackwell T, Cirangle PT, Jossart GH, Kimbrough ND, Rose JM, Stone KL, Bravata DM. Obes Surg 2010; July 2 [Epub ahead of print]
• 8 Raff H, Homar PJ, Skoner DP. Clin Chem 2003; 49: 203-204
• 9 Raff H, Raff JL, Findling JW. J Clin Endocrinol Metab 1998; 83: 2681-2686
• 10 Nater UM, Maloney E, Boneva RS, Gurbaxani BM, Lin JM, Jones JF, Reeves WC, Heim C. J Clin Endocrinol Metab 2008; 93: 703-709